ENDS 2020 conference has been postponed. Find out more

2020 Agenda

Smithers regret to inform you that ENDS 2020 will be officially postponed until later this year.

We are currently working to confirm new dates in 2020 and will provide you with updated information as soon as it becomes available!

Day One - 13 May

Wednesday 13th May

  1. Registration and welcome refreshments

  2. Chairman’s opening remarks

    John Dunne | Director of UK Vaping Industry Association

Session 1: Regulation and its current impact

  1. An update on latest US regulations

    Patricia I. Kovacevic | Global Legal & Regulatory Strategist of Regulation Strategy

  2. The ripple effect: impact of US market on the rest of the world

    Tim Phillips | Managing Director of ECigIntelligence

    • Impact of the US vaping crisis on the European vape sector
    • Key attributes of the market as the EU reviews the TPD
    • Market and regulatory impact caused on markets outside the US, particularly the EU, from the vape crisis caused by adulterated cannabis vaping products in the US
    • What individual member states have done to reflect increased consumer concern over the vaping category, and the potential impacts on a new Tobacco Products Directive.
  3. The compliance of ENDS regulations with international law

    Marina Foltea | Founder and Managing Director of Trade Pacts

    • International trade
    • Investment
    • Human rights
  4. Networking break

Session 2: Looking forward: where is the industry going?

  1. Time to be heard: what does the industry want?

    Dustin Dahlmann | President and Co-founder of Independent European Vape Alliance

    • Industry position as a tobacco independent business
    • Threats to SME sector
    • Goals towards future regulatory developments and how to achieve them
  2. Scientific cooperation for international standard developments relative to e-vapor products

    Stéphane Colard | Secretary General of CORESTA

    • Regulators and consumer expectations (including United Nations Sustainable Development Goals)
    • The responsibility of the manufacturers
    • The need for international standards
    • The value of scientific research
    • The role and activities of CORESTA on standards relative to E-vapor products
    • Update on international standards

Session 3: Production, innovation and design - practicalities and realities

  1. The role of nicotine salts

    Mark Rubinstein | VP Global Scientific Affairs of JUUL Labs

    • The role of nicotine salt technology in novel ENDS products. 
    • The pharmacokinetic and pharmacodynamic effects of the JUUL ENDS system compared to a combustible cigarette, a comparator ENDS product, and nicotine gum.
  2. Networking lunch break

  3. Device design developments

    Liam Humberstone | Technical Director at Totally Wicked of Product Design & Engineering at Independent British Vape Trade Association (IBVTA)

  4. New innovations in digital technology

    Alexandre Scheck | CEO, Co-founder ENOVAP andMarie Harang-Eltz PhD Scientific Director ENOVAP

    • Enovap: story and technology
    • Nicotine Step Down Program: first insights
    • Enovap users: data analysis

     

  5. Manufacturing and distribution

    Stephen Ryan | Business Development Manager and Owner of Superior E-Liquid

  6. Networking break

Session 4: Deep dive flavours

  1. Allergies and flavours

    Sandra Costigan | Scientific & Regulatory Affairs of British American Tobacco

    • Allergies relevant to e-liquid flavours
    • Risk management – e-liquid risk assessment, supplier quality and labelling
    • Reality check
  2. Behavioural aspects of flavours

    Ian Fearon | Consultant of whatIF? Consulting Limited

    • Review the scientific literature on use of flavoured e-cigarette products
    • Explore the idea that flavoured e-cigarettes are helpful in smoking cessation
    • Identify literature gaps and how company data can support the industry
  3. eLiquid safety and compliance – protecting flavours

    Shaun Wedgwood | Technical Director of EL-Science

    • Overview of requirements
    • Differentiating the TPD regulations from GPSR 2005
    • Industry analysis – eLiquid Safety and Compliance
    • Discussion around two studies into eliquid safety and compliance performed by EL-Science (UK Data)
    • Findings from analytical data of 1500 TPD compliant eliquid samples when compared to a Product Risk Assessment. (Global Data)
    • An overview of where EL-Science have identified areas in which the industry should focus to meet current legislation.
    • A discussion of the potential risks to the industry as a result of the USA issues surrounding eliquid safety and protecting flavours
  4. Chair’s summary and end of day one

  5. Networking drinks reception

DAY Two - 14 May

Thursday 14th May

  1. Registration and welcome refreshments

  2. Chairman’s opening remarks

    Dan Marchant | Co-Owner and founding member of the UKVIA of Vape Club

Session 5: Market challenges and the drivers for change

  1. Back to the future: the global outlook for ENDS

    Shane MacGuill | Senior Industry Manager – Tobacco of Euromonitor

    • Current global size and status of ENDS market
    • Consumer prevalence and behaviour (from Nicotine Survey)
    • Public attitudes and likely regulatory evolution
    • Future developments and ‘post-crisis’ growth potential globally
    • ENDS adjacency – vapour role in tobacco transformation and alternative applications
  2. The US youth vaping epidemic - politics or public health?

    Clive Bates | Director of Counterfactual Consulting Ltd

    • The US "youth vaping epidemic" is not what it seems
    • A drill down into the alarming headline data reveals a more complex picture
    • We need to understand who is vaping frequently and what other tobacco products they are using
    • A more nuanced picture emerges - yes, we should be concerned, but we should not over-react
  3. Overcoming market challenges: view from a flavour house start up

    Goran Krstic | CEO of Kapkas Flava

    • Starting out
    • Market focus of the company
    • Challenges of the market and what impact this has had on products, new markets and future growth potential
    • The art of flavorising
    • What lies ahead
  4. Networking break

Session 6: Environmental impact, recycling and sustainability

  1. Development and integration of a sustainable ENDS waste management initiative in New Zealand. A world first complete recycling solution

    Michael Mason | National Sales Manager EU of Alt New Zealand Limited

    • The environmental impacts of cigarette waste. Are ENDS a new problem or a solution?
    • Development of strategies for a fully-integrated and sustainable approach to manage ENDS waste in the world.
    • What can we do in the ENDS industry to build sustainable systems to address ENDS waste and the potential impact on the environment?
    • Outcomes of a fully integrated ENDS waste management system in New Zealand.
  2. Panel session: How can the industry move forward in terms of environmental impact & meeting consumer demands for greener products?

    Dan Marchant, Co-owner of Vape Club; Stéphane Colard; Michael Mason, National Sales Manager EU, Alt New Zealand Limited

Session 7: Consumers and healthcare

  1. Consumers are the only conversation

    Martin Cullip | Co-founder ETHRA of ETHRA (European Tobacco Harm Reduction Advocates)

    • Vaping is a consumer revolution, yet we are completely shut out of the conversation
    • Consumers should be central to all debates about harm reduction and included in dialogue with WHO/EU
    • ETHRA seeks to amplify the consumer voice in Europe
    • All stakeholders should be putting consumers first

     

  2. Enhancing government smoking cessation programme efficacy through strategic partnerships between ENDS industry, smoking cessation services and public hospitals — lessons from the first smoke-free hospital in New Zealand

    Eliana Golberstein Rubashkyn | Chief Scientist of Myriad Pharmaceuticals, New Zealand

    • The role of ENDS industry within governmental health care providers in NZ
    • The outcomes of successful partnerships with governmental smoking cessations programmes and the ENDS industry
    • Strategies for the vaping industry working on community-oriented projects addressing vulnerable communities
    • Lessons for the governments
  3. Networking lunch break

Session 8: Emerging markets

  1. Thoughts on the scientific assessment of heated tobacco products (and ENDS)

    Manuel Peitsch | Chief Scientific Officer of Philip Morris International

    • Fundamental principles
    • Nature-imposed challenges
    • Addressing these challenges with new approaches and rigorous methods
    • Outlook and conclusions
  2. The importance of a diverse portfolio of potentially reduced risk tobacco and nicotine products for emerging markets

    David O'Reilly | Director Scientific Research of British American Tobacco

    • our approach is to innovate in three major categories with risk reduction potential - tobacco heating products, vapour products and modern oral
    • this presentation will use the science behind each category and country case studies to show why this is important
  3. The future of oral tobacco and nicotine products

    Tryggve Ljung | VP Scientific Affairs of Swedish Match

    • Swedish snus was a consumer driven health revolution
    • The EU snus ban vs. US MRTP order
    • The science behind next generation oral products vs. policy

     

  4. CBD and its place in the industry

    Arnaud Cohen | President ACTIVE France and Sales Director, Harmony of Harmony

  5. Chair’s closing remarks and end of conference